Sitka Biopharma to initiate Phase I trial of STK-01 to treat bladder cancer

Canada-based biotechnology firm Sitka Biopharma has entered an agreement with Cancer Research UK and Cancer Research Technology (CRT) to start a Phase I clinical trial of STK-01 for treatment of patients with bladder cancer. (Source: Drug Development Technology)

from MedWorm via o.lakala70 on Inoreader http://ift.tt/2tm8XtV
via IFTTT